Note: Cullinan Oncology's revenues are gauged from an analysis of company filings.
Cullinan Oncology's Income Statement (based on Industry Averages)
Cullinan Oncology P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Cullinan Oncology is developing and marketing.
Cullinan Oncology doesn't have any recent trademark applications, indicating Cullinan Oncology is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
CULLINAN Advice relating to investments; Brokerage services for capital investments; Business brokerage services and related consulting pertaining to business sales, mergers, acquisitions and business valuations; Business equity research; Business finance procurement services; Capital investment; Capital investment consulting; Capital investment services; Consultancy of capital investment; Debt management consultation; Equity capital investment; Facilitating and arranging for the financing of start up ventures in the field of oncology, pharmaceuticals, and therapeutics; Fiduciary representatives; Financial advice; Financial advice and consultancy services; Financial advisory and consultancy services; Financial and investment services, namely, asset and investment acquisition, consultation, advisory and development; Financial consultancy; Financial consultancy services in the area of healthcare; Financial consultation; Financial consultation in the field of oncology and therapeutic products for the pharma industry; Financial consulting; Financial due diligence; Financial investment in the field of oncology and therapeutic products for the pharma industry; Financial loan consultation; Financial portfolio management; Financial research and information services; Financial restructuring services; Financial services in the nature of an investment security; Financial services, namely, raising debt and equity capital for others; Fundraising for others for the purpose of purchasing companies; Funds investment; Incubation services, namely, providing financing to freelancers, start-ups, existing businesses and non-profits; Incubation services, namely, rental of office space to freelancers, start-ups, existing businesses and non-profits; Information, advisory, consultancy and research services relating to finance and investments; Investment advisory services; Investment consultancy; Investment consultation; Investment management; Investment management in the fields of oncology and therapeutic products for the pharma industry; Investment management services in the field of acquiring joint ventures; Investment services, namely, asset acquisition, consultation, development and management services; Management of a capital investment fund; Management of private equity funds; Mutual funds and capital investment; Private equity consultant services; Private equity fund investment services; Providing financial information; Providing fundraising services for others via a global computer network; Providing investors with financial information; Providing loans secured by commercial paper; Providing venture capital, development capital, private equity and investment funding; Providing working capital; Providing working capital financing to small businesses and small business owners; Provision of financial information; Public equity investment management; Strategic corporate financial advisory services; Strategic financial advisory services; Venture capital advisory services; Venture capital financing; Venture capital fund management; Venture capital funding services to emerging and start-up companies; Venture capital services, namely, providing financing to emerging and start-up companies
10/06/2016
See all trademarks and details in the Full Report.
Market Share of Cullinan Oncology's Largest Competitors
A competitive analysis shows these companies are in the same general field as Cullinan Oncology, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Cullinan Oncology.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Cullinan Oncology and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.